Acetazolamide Tablets IP 250 mg Supplier in India – Healthy Inc

Acetazolamide Tablets IP 250 mg | Supplier
Product image for Acetazolamide Tablets IP 250 mg Supplier; wholesale & institutional bulk supply.
Product Information
| Generic Name | Acetazolamide |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049081 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Diuretic and Antiglaucoma Preparations |
| Subcategory | Carbonic Anhydrase Inhibitors |
| Active Ingredient | Acetazolamide |
| Strength | 250 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Ophthalmologicals / Diuretics - Carbonic Anhydrase Inhibitors |
Medicine Details & Safety
| Short Description | Healthy Inc invites B2B supply enquiries for Acetazolamide Tablets IP 250 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Open-Angle Glaucoma: Chronic simple open-angle glaucoma and secondary glaucoma as adjunctive therapy. 2. Acute Angle-Closure Glaucoma: Preoperative short-term management to rapidly decrease intraocular pressure. 3. Acute Mountain Sickness (AMS): Prophylaxis and symptomatic treatment in high-altitude ascents. 4. Edema: Adjunctive management of abnormal fluid retention in congestive heart failure and drug-induced edema. 5. Epilepsy: Adjunctive treatment of generalized tonic-clonic, absence, or partial seizures. | ||||||||||||||||||||||||||||||||||
| Full Description | Healthy Inc invites B2B supply enquiries for Acetazolamide Tablets IP 250 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. Product technical specifications
Product technical specifications
Supply channels and buyer segmentsHospital procurement teams and institutional tender buyers can submit tender specifications, required documentation and staggered delivery schedules. Wholesalers and pharmacy chains can request pack configurations and replenishment planning. PCD distributors may submit territory and commercial requirements for review.Commercial supply matrix
Inventory and batch traceabilityRequest available batch numbers, expiry details, COA and approved storage conditions for Acetazolamide Tablets IP 250 mg. Agree minimum remaining shelf life and stock rotation requirements before dispatch.Procurement and deliverySubmit purchase quantity, delivery location, buyer licence details and required documents. Confirm commercial terms, payment conditions, transport arrangements and repeat-order schedule. Stock and delivery are not guaranteed until confirmed. | ||||||||||||||||||||||||||||||||||
| Dosage Instructions | Dosage depends upon the target indication: - Open-Angle Glaucoma: 250 mg (1 tablet) one to four times daily (250 mg to 1,000 mg/day in divided doses). - Acute Angle-Closure Glaucoma: 250 mg every 4 hours or initial 500 mg followed by 250 mg every 4 to 6 hours. - Acute Mountain Sickness: 125 mg to 250 mg twice daily, starting 24 to 48 hours prior to ascent and continued for 48 hours at summit altitude. - Edema / Diuresis: 250 mg to 375 mg once daily in the morning on alternate days or consecutive 2-day cycles to avoid refractory tolerance. | ||||||||||||||||||||||||||||||||||
| Side Effects | Common (1-10%): Paresthesias (tingling/numbness in fingers and toes), polyuria, transient taste alteration (dysgeusia, carbonated beverages taste flat), fatigue, mild nausea. Uncommon (0.1-1%): Mild metabolic acidosis, electrolyte imbalances (hypokalemia, hyponatremia), loss of appetite, somnolence, confusion. Rare (<0.1%): Severe sulfonamide-type allergic reactions, Stevens-Johnson syndrome, agranulocytosis, aplastic anemia, nephrolithiasis (calcium kidney stones). | ||||||||||||||||||||||||||||||||||
| Warnings and Precautions | Acid-Base & Electrolyte Balance: Prolonged therapy may lead to hyperchloremic metabolic acidosis and severe hypokalemia; monitor serum electrolytes regularly. Sulfonamide Cross-Reactivity: Potential for severe cutaneous adverse reactions (SJS/TEN) and hematologic dyscrasias. Hepatic Impairment: Strictly contraindicated in severe cirrhosis due to increased risk of precipitating hepatic encephalopathy. | ||||||||||||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to acetazolamide or other sulfonamide derivatives. 2. Marked hepatic failure, cirrhosis, or risk of hepatic encephalopathy. 3. Severe renal impairment (GFR < 10 mL/min). 4. Depressed sodium or potassium serum levels (hyponatremia, hypokalemia) and hyperchloremic acidosis. 5. Adrenocortical insufficiency (Addison's disease). 6. Long-term use in chronic non-congestive angle-closure glaucoma. | ||||||||||||||||||||||||||||||||||
| Drug Interactions | 1. High-Dose Aspirin (Salicylates): Concomitant use can cause severe metabolic acidosis and increase acetazolamide central nervous system toxicity; avoid combination. 2. Digoxin / Cardiac Glycosides: Acetazolamide-induced hypokalemia significantly increases the risk of digitalis toxicity and life-threatening arrhythmias. 3. Antidiabetic Agents (Metformin / Sulfonylureas): May potentiate hypoglycemia or worsen metabolic acidosis risk. 4. Lithium: Acetazolamide promotes renal excretion of lithium, significantly reducing its therapeutic blood levels. 5. Quinidine & Amphetamines: Urinary alkalinization delays renal excretion, elevating blood levels and toxicity. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Who can request bulk supply for Acetazolamide Tablets IP 250 mg? | Licensed pharmaceutical wholesalers, distributors and institutional procurement teams can submit enquiries. |
| What is the minimum order quantity for Acetazolamide Tablets IP 250 mg? | MOQ is confirmed according to pack configuration and order requirements. |
| Is ready stock available for Acetazolamide Tablets IP 250 mg? | Request current stock and batch availability before placing an order. |
| Can institutional tender requirements be supported for Acetazolamide Tablets IP 250 mg? | Submit tender specifications and delivery schedule for feasibility review. |
| How can I request wholesale pricing for Acetazolamide Tablets IP 250 mg? | Provide quantity, delivery location and required packaging for a quotation. |
